Percutaneous penetration of ozagrel and the enhancement produced by saturated fatty acids

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 7, 2000, Pages 844-849

  Ogiso, Taro ^a   Koike, Kazunori ^a   Iwaki, Masahiro ^a   Tanino, Tadatoshi ^a   Tanabe, Genzou ^a   Muraoka, Osamu ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Co penetrant; Fatty acid enhancement; Ozagrel; Percutaneous penetration; Rat skin

Indexed keywords

LAURIC ACID; OZAGREL; SATURATED FATTY ACID;

ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENCY; MALE; NONHUMAN; PARTITION COEFFICIENT; RAT; SKIN PENETRATION; STRATUM CORNEUM;

EID: 0033926229     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.844     Document Type: Article

References (29)

1. Iizuka K., Akahane K., Momose D., Nakazawa M., J. Med. Chem., 24, 1139-1148 (1981).
2. Hiraku S., Taniguchi K., Wakitani K., Omawari N., Kira H., Miyamoto T., Okegawa T., Kawasaki A., Ujiie A., Jpn. J. Pharmacol., 41, 393-401 (1986).
3. Makino S., Miyamoto T., Takishima T., Shida T., Nagano H., Nakashima M., Hanaoka K., Rinsho Iyaku, 6, 2131-2166 (1990).
4. Nishiyama M., Miyagi M., Ikeda S., Sawada M., Ishido M., Kajihara I., Okekawa T., Kiso To Rinsho, 24, 3763-3788 (1990).
5. Sawada M., Nakausa M., Yano T., Yamamoto R., Okegawa T., Kiso To Rinsho, 24, 3803-3809 (1990).
6. Fukushima M., Kubo K., Yoshimura K., Shibamoto T., Fujimoto K., Hirai K., Kobayashi T., Kusama S., Komatsu H., Hamano S., Ujiie A., Shimizu M., Miyagi M., Morita K., Mikoshiba I., Hiraku S., Ohki S., Yakari To Chiryo, 14, 1373-1403 (1986).
7. Fukushima M., Kubo K., Yoshimura K., Shibamoto T., Yazaki K., Kobayashi T., Handa K., Kusama S., Komatsu H., Shimizu M., Miyagi K., Mikoshiba I., Saito H., Hiraku S., Ohki S., Kiso To Rinsho, 24, 3215-3237 (1990).
8. Sawada M., Ishido M., Masuda H., Okegawa T., Nishiyama M., Miyagi M., Ikeda S., Kiso To Rinsho, 24, 3791-3801 (1990).
9. Burnette R. R., Ongpipattanakul B., J. Pharm. Sci., 77, 132-137 (1988).
10. Bennett S. L., Barry B. W., J. Pharm. Pharmacol., 37 (Suppl.), 84P (1985).
11. ) Cooper E., Merrill E., Smith R., J. Pharm Sci., 74, 688-689 (1985).
12. Aungst B. J., Rogers N. J., Sehefter E., Int. J. Pharm., 33, 225-234 (1986).
13. Kaiho F., Nomura H., Makabe E., Kato Y., Chem. Pharm. Bull., 35, 2928-2934 (1987).
14. Barry B. W., J. Controlled Release, 6, 85-97 (1987).
15. Walters K. A., "Transdermal Drug Delivery. Developmental Issues and Research Initiatives." ed. by Hadgraft J., Guy R. H., Marcel Dekker, New York, 1989, pp. 197-246.
16. Ogiso T., Shintani M., J. Pharm. Sci., 79, 1065-1071 (1990).
17. Kim C. K., Kim J., Chi S., Shim C., Int. J. Pharm., 99, 109-118 (1993).
18. Naik A., Pechtold L. A. R. M., Potts R. O., Guy R. H., J. Controlled Release, 37, 299-306 (1995).
19. Kligman A. M., Christophers E., Arch. Dermatol., 88, 702-705 (1963).
20. Ogiso T., Niinaka N., Iwaki M., J. Pharm. Sci., 85, 57-64 (1996).
21. Keith A., Bulfield G., Snipes W., Biophys. J., 10, 618-626 (1970).
22. Chein T. W. (ed.), "Transdermal Controlled Systemic Medications," Marcel Dekker, New York, 1987, pp. 25-82.
23. Ruland A., Kreuter J., Int. J Pharm., 85, 7-17 (1992).
24. Kurosaki Y., Nagahara N., Tanizawa T., Nishimura H., Nakayama T., Kimura T., Int. J. Pharm., 67, 1-9 (1991).
25. Ogiso T., Hirota T., Iwaki M., Hino T., Tanino T., Int. J. Pharm., 176, 63-72 (1998).
26. Tanojo H., Bouwstra J. A., Junginger H. E., Bodde H. E., Pharm. Res., 14, 42-49 (1997).
27. Blume A., Jansen M., Ghyczy M., Gareiss J., Int. J. Pharm., 99, 219-228 (1993).
28. Blank I. H., Scheuplein R. J., Br. J. Derm., 81 (Suppl. 4), 4-10 (1969).
29. Kissei Pharmaceutical Co., "Interview form for domenan (ozagrel) tablet," 1992, p. 4.